RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @MattersoftheH14: .
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @karina_lupercio: En resumen sobre terapia antitrombótica en TAVR
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @karina_lupercio: En resumen sobre terapia antitrombótica en TAVR
RT @karina_lupercio: En resumen sobre terapia antitrombótica en TAVR
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
.
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @GilbertTangMD: Important #ACC21 #TAVR #HALT in BE/ME THV summarized by @hahn_rt. Under expansion, deep implant and Commissural misalign…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @Serginho1409: Trombosis valvular post TAVI. Factores de Riesgo, factores asociados. #TAVI #echo #Thrombose https://t.co/zF1fOkHHsn
Trombosis valvular post TAVI. Factores de Riesgo, factores asociados. #TAVI #echo #Thrombose
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
Important #ACC21 #TAVR #HALT in BE/ME THV summarized by @hahn_rt. Under expansion, deep implant and Commissural misalignment ⬆️HALT. Comments? @djc795 @OKhaliqueMD @JoaoLCavalcante @KHERA_MD @IHamamsy @NimeshDesaiMD @tomcnguyen We true/undersize S3 & o
RT @hahn_rt: Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitt…
Interesting abstracts on #TAVR thrombosis from #ACC21. Access ACC science on demand here: https://t.co/VAyO0ucrRo #CardioTwitter #echofirst @Heart_SCCT @ASE360 @JACCJournals @PPibarot @HeartOTXHeartMD @GilbertTangMD @FabienPraz #CardioTwitter See also htt
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
RT @Argenscore: EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: H…
EVOLUT LOW RISK SUB-STUDY TAVR:197/SAVR:178 4D CT 30 days: HALT: 16.9% / 17.3% p=0.85 RLM: 14.6% / 14.3% p=0.48 1 y.: HALT: 30.9/28.4 RLM: 31/27 Subclinical V thrombosis Frequent Dynamic Not associated w/worsening valve hemodynamics/clinical events
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @hect2701: "#CT abnormalities of aortic bioprostheses were frequent but dynamic in the 1st yr after self-expanding transcatheter & surgi…
"#CT abnormalities of aortic bioprostheses were frequent but dynamic in the 1st yr after self-expanding transcatheter & surgical aortic valve replacement, but these findings did not correlate w aortic valve hemodynamic status in pts at low risk." http
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @AChoiHeart: Congratulations to the study investigators on this important study from #ACC20 In this study of Evolut (eg supra-annular,…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
RT @JACCJournals: The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening…
The Evolut Low-Risk Study investigated the frequency, predictors & hemodynamic/clinical correlates of leaflet thickening & reduced leaflet motion following #TAVR. Drs. @JonathonLeipsic, @PopmaJeffrey et al. share their #ACC20/#WCCardio research in
Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-Study | JACC: Journal of the American College of Cardiology https://t.co/U26JrWINZE
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @PPibarot: Similar rates of HALT and RLM in TAVR vs. SAVR in EVOLUT LR trial. Leaflet Thickening or Immobility Following Aortic Valve Re…
RT @GilbertTangMD: How does #Evolut LR CT substudy compare to P3 CT substudy? #HALT incidence similar? #TAVR @djc795 @PPibarot @JoaoLCavalc…
RT @PPibarot: Similar rates of HALT and RLM in TAVR vs. SAVR in EVOLUT LR trial. Leaflet Thickening or Immobility Following Aortic Valve Re…
RT @PPibarot: Similar rates of HALT and RLM in TAVR vs. SAVR in EVOLUT LR trial. Leaflet Thickening or Immobility Following Aortic Valve Re…
RT @GilbertTangMD: How does #Evolut LR CT substudy compare to P3 CT substudy? #HALT incidence similar? #TAVR @djc795 @PPibarot @JoaoLCavalc…
RT @PPibarot: Similar rates of HALT and RLM in TAVR vs. SAVR in EVOLUT LR trial. Leaflet Thickening or Immobility Following Aortic Valve Re…
RT @GilbertTangMD: How does #Evolut LR CT substudy compare to P3 CT substudy? #HALT incidence similar? #TAVR @djc795 @PPibarot @JoaoLCavalc…
How does #Evolut LR CT substudy compare to P3 CT substudy? #HALT incidence similar? #TAVR @djc795 @PPibarot @JoaoLCavalcante @tomcnguyen @TsuyoshiKaneko1 @chrismeduri @anvoramd @PopmaJeffrey @DrMoritzWvB @PhilGenereuxMD @OKhaliqueMD
RT @dr_cfp: Leaflet #thrombosis after #TAVR,using #angiotomography https://t.co/Nnw7pAlymO
#EAPCI @PCRonline
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
Similar rates of HALT and RLM in TAVR vs. SAVR in EVOLUT LR trial. Leaflet Thickening or Immobility Following Aortic Valve Replacement: Results from the Evolut Low Risk Sub-study | JACC: Journal of the American College of Cardiology https://t.co/jvYdTJDcw3
Leaflet #thrombosis after #TAVR,using #angiotomography https://t.co/Nnw7pAlymO
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…
RT @JACCJournals: Leaflet thrombosis has been reported after bioprosthetic AVR w/ 4-D #YesCCT by hypoattenuated leaflet thickening & reduce…